It has recently been reported that NOTCH2, activated via delta-like ligand 1, inhibits the EBV lytic cycle in the EBV-infected B-cell non-Hodgkin's lymphoma line by upregulating the cellular transcription factor Zeb2, which represses BZLF1 expression. Here, DLL1 is linked to B-cell non-Hodgkin lymphoma.